The effect of 1,25 dihydroxycholecalciferol on parathyroid hormone secretion by monolayer cultures of bovine parathyroid cells
- PMID: 3079648
- DOI: 10.1007/BF02556591
The effect of 1,25 dihydroxycholecalciferol on parathyroid hormone secretion by monolayer cultures of bovine parathyroid cells
Abstract
Controversy exists over a direct effect of 1,25(OH)2D3 on PTH secretion. To investigate the possibility that the suppressive effect of 1,25(OH)2D3 on PTH secretion may be demonstrable in 1,25(OH)2D3-depleted tissue and/or after prolonged periods of exposure to 1,25(OH)2D3, primary monolayer cultures of bovine parathyroid cells were established in 1:1 DMEM/Ham's F-12 media supplemented with 2% calf serum but not 1,25(OH)2D3. Ionized calcium was maintained at 1.0 mM. Experiments were performed on 4-day-old culture cells. PTH concentration was measured using both a mid-region/carboxyl and an amino-terminal PTH antisera. 1,25(OH)2D3 at a concentration of 0.1 ng/ml suppressed PTH secretion by 32 +/- 7% after 48 hours. High calcium concentration (2.0 mM) suppressed PTH secretion by 37 +/- 10% and this effect was not additive over that of 1,25(OH)2D3. PTH secretion rate recovered fully 48 hours after normalization of the external calcium concentration but not after the removal of 1,25(OH)2D3. It is concluded that 1,25(OH)2D3 directly suppresses PTH secretion by monolayer culture of bovine parathyroid cells.
Similar articles
-
1,25(OH)2D3 inhibits hormone secretion and proliferation but not functional dedifferentiation of cultured bovine parathyroid cells.Calcif Tissue Int. 1988 Oct;43(4):213-8. doi: 10.1007/BF02555137. Calcif Tissue Int. 1988. PMID: 3145126
-
1,25-Dihydroxyvitamin D3 suppresses parathyroid hormone secretion from bovine parathyroid cells in tissue culture.Endocrinology. 1985 Nov;117(5):2114-9. doi: 10.1210/endo-117-5-2114. Endocrinology. 1985. PMID: 3840080
-
Effects of 1,25- and 24,25-dihydroxycholecalciferol on parathyroid hormone release from human parathyroid cells in vitro.Acta Endocrinol (Copenh). 1984 Mar;105(3):354-9. doi: 10.1530/acta.0.1050354. Acta Endocrinol (Copenh). 1984. PMID: 6608201
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
-
The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion.Contrib Nephrol. 1991;91:123-8. doi: 10.1159/000420167. Contrib Nephrol. 1991. PMID: 1800003 Review.
Cited by
-
PTH ablation ameliorates the anomalies of Fgf23-deficient mice by suppressing the elevated vitamin D and calcium levels.Endocrinology. 2011 Nov;152(11):4053-61. doi: 10.1210/en.2011-1113. Epub 2011 Sep 6. Endocrinology. 2011. PMID: 21896668 Free PMC article.
-
Vitamin D metabolism: new concepts and clinical implications.Clin Biochem Rev. 2003;24(1):13-26. Clin Biochem Rev. 2003. PMID: 18650961 Free PMC article.
-
The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion.J Clin Invest. 1989 Sep;84(3):728-32. doi: 10.1172/JCI114229. J Clin Invest. 1989. PMID: 2760211 Free PMC article.
-
Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients.J Clin Invest. 1993 Sep;92(3):1436-43. doi: 10.1172/JCI116720. J Clin Invest. 1993. PMID: 8397225 Free PMC article.
-
Oncogenic osteomalacia caused by a phosphaturic mesenchymal tumor of the oral cavity: a case report.Korean J Intern Med. 1997 Jan;12(1):89-95. doi: 10.3904/kjim.1997.12.1.89. Korean J Intern Med. 1997. PMID: 9159046 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Miscellaneous